Alerts will be sent to your verified email
Verify EmailJEL
|
Jyotirgamya
|
Supha Pharmachem
|
Welcure Drugs&Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 38.8 % | 45.81 % |
|
5yr average Equity Multiplier
|
1.28 | 60.3 | -0.38 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 1.25 | 0.25 |
|
5yr Avg Net Profit Margin
|
-62.2 % | 0.65 % | -80.17 % |
|
Price to Book
|
11.97 | 0.35 | 0.27 |
|
P/E
|
0.0 | 17.4 | 1.01 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 478.33 Days | 2364.01 Days |
|
Inventory Days
|
182.3 Days | 78.27 Days | 20.66 Days |
|
Days Receivable
|
0.0 | 694.98 Days | 1232.42 Days |
|
Days Payable
|
0.0 | 156.76 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
-10.25 | 9.58 | -2.67 |
|
5yr Avg ROCE
|
-0.35 % | 66.83 % | -7.19 % |
|
5yr Avg Operating Profit Margin
|
-121.65 % | 0.73 % | -81.01 % |
|
5 yr average Debt to Equity
|
0.0 | 6.84 | -0.35 |
|
5yr CAGR Net Profit
|
-19.73 % | 14.55 % | -2.01 % |
|
5yr Average Return on Assets
|
-0.3 % | 0.69 % | -1.33 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
5.33 % | 1.13 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-61.18 % | 0.02 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Jyotirgamya
|
Supha Pharmachem
|
Welcure Drugs&Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|